9h00 – 12 h00: Two parallel sessions

• Session A – « French Young researchers in medical imaging »: FINYS (French Imaging Network of Young Scientists), at the “Petit Théâtre” – Presentations will be selectd by a specific review committee.
• 9h00 – 9h15: Presentation of FINYS – Introduction – Carine KRONLAND-MARTINET, Jonathan VIGNE
• 9h15 – 10h30: Technological Innovations in in-vivo Imaging 5 Flash Presentations (5min presentation + 10 min questions)
• 10h30 – 10h45: Pause
• 10h45 – 12h00: Clinical Innovations using In-vivo imaging 5 Flash Presentations (5min presentation + 10min questions)
• 12h00 – 12h45: FINYS plenary meeting
• 12h45 – 13h45: Lunch

• Session B – Session organized by the four LabEx working in the field of In Vivo Imaging TRAIL, IRON, CAMI, PRIMES, main room
• 9h15 – 9h30: Accueil
• 9h00 – 10 h10: LabEX Trail
• 9h30: Encodage non-cartésien de l’espace de Fourier: applications en IRM préclinique – Sylvain MIRAUX (CMRDB Bordeaux)
• 9h50: Ultrasons focalisés guidés par IRM: du petit animal jusqu’au patient – Bruno QUESSON (IHU Liryc, Bordeaux)
• 10h10 – 10h50: LabEX PRIMES
• 10h10: Recalage déformable en radiothérapie guidée par l’image – David SARRUT (Creatis Lyon)
• 10h30: Analyse statistique d’images paramétriques multimodales pour le bilan non invasif préchirurgical de l’épilepsie focale pharmaco-résistante – Carole LARTIZIEN (Creatis, Lyon)
• 10h50 – 11h10: Coffee break
• 11h10 – 11h50: LabEX IRON
• 11h10: Développement d’un radiopharmaceutique: de la pertinence biologique aux difficultés réglementaires – Mickaël BOURGEOIS (CHU Nantes)
• 11h30: La texture et l’imagerie TEP: principe et intérêt pronostique dans les lymphomes du manteau – Clément BAILLY
• 11h50 – 12h30: LabEX CAMI
• 11h50: A Computer Vision Approach to Radiation Exposure Monitoring in the Hybrid Operating Room – Nicolas PADOY (ICube, Strasbourg)
• 12h10: Computer Assisted Prostate Brachytherapy Interventions – Marie-Paule GARCIA (Latim U1101, Brest)

13h45 – 14h00: Opening of the plenary sessions: Franck Lethimonnier, AVIESAN ITMO Technologie pour la Santé – FLI

14h00 – 16h20: Session 1: Early Diagnosis
• 14h00 – 15h00: Lung Cancer – Chairpersons: Charles André CUENOD / Daniel FAGRET
– 14h00 – 14h20: A retrospective analysis of the published papers – Bernard Milleron (Hôpital Tenon et Président honoraire de l’IFCT, Paris)
– 14h20 -14h40: Methods of Data acquisition and analysis of the CT scans – Gilbert Ferretti (CHU Grenoble)
– 14h40 – 15h: What are the main requirements before implementation ? – Sébastien Couraud (Hospices Civils de Lyon)

• 15h00 – 16h20: Stroke – Chairperson: Vincent DOUSSET
– 15h00 – 15h20: Pathophysiology and imaging of the early phase of stroke – Yves Berthezene (CREATIS UMR CNRS 5220 U1044 Inserm – Hôpital Neurologique, Service de Radiologie – Lyon)
– 15h20 – 15h40: Diagnosis MRI Biomarkers at accute phase – Catherine Oppenheim (Hôpital Sainte-Anne, AP-HP, Paris)
– 15h40 – 16h00: Pronostic MRI Biomarkers at accute phase – Thomas Tourdias (CHU Bordeaux)
– 16h00 – 16h20: Therapeutic interventional impact – Alain BONAFÉ (CHU Montpellier)

16h20 – 17h00: Coffee break

17h00 – 19h00: Session 2: Interventional Imaging – Chairpersons: Jean-Michel BARTOLI / Michel de MATHELIN
• 17h00 – 17h30: Chemo-embolization with novel antitumor agents : Boris GUIU (CHRU Montpellier)
• 17h30 – 18h00: Focused UltraSounds: Cyril LAFON (Labtau, Lyon) / Olivier ROUVIERE (Hôpital E. Herriot, Lyon)
• 18h00 – 18h30: Interventional MR Imaging: Afshin GANGI (Chef du pôle d’imagerie Interventionnelle, Nouvel Hopital Civil, Strasbourg) – Michel DE MATHELIN (Directeur du laboratoire I-Cube, Strasbourg)
• 18h30 – 19h00: Robotic assisted interventional imaging : Ivan BRICAULT, Céline FOUARD et Philippe CINQUIN, CHU Grenoble Alpes, Laboratoire TIMC-IMAG, Université Grenoble Alpes

9h00 – 13h00: Session 3: Companion test and theranostic / Session 4: Recurrence of cancer detection

9h00 – 10h15: Session 3: Companion test and theranostic – Chairpersons: Françoise BODERE-KRAEBER / Bernard VAN BEERS
• 9h00 – 9h25: Breast cancer: A model for companion / Theranostic in nuclear medicine – Dr Caroline ROUSSEAU (Institut de Cancérologie de l’Ouest, René Gauducheau and CLCC Nantes (Saint-Herblain))
• 9h25 – 9h50: Theranostic and Ultrasounds: Olivier COUTURE (Institut Langevin, ESPCI, Paris)
• 9h50 – 10h15: Theranostic approaches using oxide iron particles and MRI: Florence GAZEAU (Laboratoire Matière et Systèmes Complexes, CNRS Université Paris Diderot)

10h15 – 10h45: Coffee break

10h45 – 12h00: Session 4: Detection of Cancer recurrences – Chairpersons: Olivier MUNDLER / Isabelle BERRY
• 10h45 – 11h10: Neuroendocrine and thyroïde tumors – Aurélien ARCHIER, David TAÏEB (CHU la Timone, CERIMED, université de la méditerranée, Marseille, France)
• 11h10 – 11h35: Factors enabling the prediction of glioblastoma recurrence – Anne LAPRIE INSERM 825 et Institut Universitaire du Cancer de Toulouse
• 11h35 – 12h00: Contrast imaging using US Olivier LUCIDARME (Laboratoire d’Imagerie Fonctionnelle – U678, Faculté de Médecine Pierre et Marie Curie
et Hôpital Pitié Salpêtrière)

12h00 – 13h00: Round table of the sessions 3 and 4 
Fostering Innovation in the field of drug development, medical devices and acts in France: Strengths and bottlenecks ?
Introduction: Support to innovation in the field of drug development, medical devices and innovative acts: ANSM representative
Discussion with: Olivier MUNDLER, Bernard VAN BEERS, Olivier COUTURE, François SIGAUX and the ANSM representative

13h00 – 14h00: Lunch break

14h00 – 16h00: Posters

16h00 – 18h00: Round table Europe – Coordination of European projects by French researchers: Is it an issue? Where are the bottlenecks?
Introduction: How many European projects involve in vivo imaging? How many of them are leaded by French researchers? How to improve this?
Animators: Gabriel P. KRESTIN, M.DM, PhD. (Department of Radiology and Nuclear medicine, Erasmus MC, University Medical Centre Rotterdam and the European Institute for Biomedical Imaging Research), Nacer BOUBENNA (Coordinateur du Point de Contact National du défi Santé d’Horizon 2020 à l’Inserm)
Participants: Guy COURBEBAISSE (Projet Européen Thrombus FP7 et COST modélisation), Bertrand TAVITIAN (EMIL), Olivier BLIN (Pharmacog)

• 16h00 – 16h20: European Health Research Funding and the Role of the European Institute for Biomedical Imaging Research. Gabriel KRESTIN, Head Department of Radiology, Erasmus Medical Centre – Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Centre Rotterdam and the European Institute for Biomedical Imaging.
• 16h20 – 16h40: Nacer BOUBENNA – Coordinator of the French contact point for the Healthcare European Research Council challenge at Inserm.

Participants THROMBUS: Guy COURBEBAISSE (PI et Coordinateur du Projet européen Thrombus – CREATIS – CNRS UMR 5220)
Participants EMIL: Bertrand TAVITIAN (Coordinateur du programme EMIL)
Participants PHARMACOG: Olivier BLIN (Coordinateur du programme)

8h30 – 11h00: Session 5: Technological breakthrough – Chairperson: Lori BRIDAL (UPMC Paris 6 – CNRS UMR 7371 – INSERM U 1146, Paris), Monique BERNARD (CRMBM Marseille)
• 8h30 – 8h50: Fast Ultrasounds for functional imaging: Mickael TANTER
• 8h50 – 9h10: MultiNuclei imaging and Ultra-High Field MR imaging – Cyril POUPON (NeuroSpin, CEA)
• 9h10 – 9h30: In-vivo optical Imaging : endogenous optical contrast of tissues – Anne PLANAT-CHRÉTIEN (CEA-LETI, MINATEC, Grenoble) et Jérôme GATEAU (Université Paris Descartes, Paris)
• 9h30 – 9h50: New imaging contrasts using X rays : Francoise PEYRIN (CREATIS, CNRS 5220, INSERM U1044, INSA Lyon, Université de Lyon, Villeurbanne), Christian MOREL (Aix Marseille)
• 9h50 – 10h10 : Big and heterogeneous data analysis : Bertrand THIRION (NeuroSpin, Saclay)

10h15 – 11h00: Round table: Multi modalities imaging with PET imaging led by Denis GUILLOTEAU (Director of the in-vitro nuclear medicine center ; director of the Inserm u930 unit ‘imaging and brain’, Bretonneau hospital, Tours)

11h00 – 11h30: Coffee break

11h30 – 13h30: Presentation from the industrial partners: The session is led by the «Domaine d’Actions Stratégiques Imagerie diagnostique et Interventionnelle du pôle de compétitivité MEDICEN”. Chairperson: Alexandre DA COSTA

13h30 – 14h30: Lunch Break

14h30 – 17h00: Session 6: Therapeutic Evaluation – Chairpersons: Irène BUVAT, Maxime GUYE, Laure FOURNIER
• 14h30 – 15h00: Definition of an ideal biomarker for therapeutic evaluation? What are the steps leading to the validation of an imaging biomarker? – Olivier BLIN (Service de Pharmacologie Clinique, Piici, Institut de Neurosciences Cognitives, Aix-Marseille Université, APHM, Marseille)
• 15h00 – 15h20: Ultrasound contrast agents for therapy monitoring and evaluation – Ayache BOUAKAZ (Inserm UMR U930 – Université François RABELAIS de Tours, France)
• 15h20 – 15h40: What is the role of the preclinical models in the process of therapeutic evaluation – Marc DHENAIN (MIRCen/ CEA, Fontanay-aux-Roses)
• 15h40 – 16h00: PET imaging: a possible candidate as a biomarker of tbc – Dominique LE GULUDEC, Fabien HYAFIL (Service de Médecine Nucléaire, CHU Bichat, DHU FIRE, AP-HP, Inserm 1148, FRIM, Université Paris 7)
• 16h00 – 16h20: Na MRI: is it a biomaker of neurodegenerescence ? – Bertrand AUDOIN (CRMBM, Marseille)
• 16h20 – 17h00: Discussion : Irène BUVAT, Maxime GUYE, Laure FOURNIER, Marc DHENAIN

17h00 – 17h15: Conclusion of the congress

Franck LETHIMONNIER, Régine TRÉBOSSEN, Olivier CLÉMENT, Nicolas GRENIER, Jean-Philippe VUILLEZ

Scientific Subcommittee:

– Early diagnosis: Daniel FAGRET, Vincent DOUSSET, Charles-André CUENOD
– Companion test and theranostic: Francoise BODERE-KRAEBER, Bernard VAN BEERS, Olivier COUTURE
– Therapeutic evaluation: Maxime GUYE, Irène BUVAT, Laure FOURNIER
– Technological breakthrough: Luc DARRASSE, Pascal LAUGIER, Christian MOREL, Jean-Marc DINTEN, Denis GUILLOTEAU, Francoise PEYRIN
– Interventional imaging: Michel DE MATHELIN Jean-Michel BARTOLI, Philippe CINQUIN, Cyril LAFON
– Cancer recurrence detection: Olivier MUNDLER, Francois SIGAUX, Isabelle BERRY
– Industry presentations: Alexandre DA COSTA
– Young scientists presentations: Lauranne DUQUENNE et Vivienne FARDEAU

Organization committee : 
Camille ARNAUD, Frédérique FROUIN, Laurent MENARD, Marie-Hélène GAUGLER, Lauranne DUQUENNE, Maxime LOCATELLI, Régine TRÉBOSSEN, Pierre WILTZ

The official language for the slides will be English. The choice of the language for the presentations is free (English or French) except for the round table on European projects for which the language will be English.